Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
transaction | NVAX | Stock Option (Right to Buy) | Award | $0 | +44.3K | $0.00 | 44.3K | Mar 7, 2023 | Common Stock | 44.3K | $6.97 | Direct | F1 | |
transaction | NVAX | Restricted Stock Units | Award | $0 | +38.3K | $0.00 | 38.3K | Mar 7, 2023 | Common Stock | 38.3K | Direct | F2, F3 |
Id | Content |
---|---|
F1 | Twenty-five percent (25%) of the shares subject to this option grant under the Novavax, Inc. (the "Company") Amended and Restated 2015 Stock Incentive Plan, as amended (the "Plan"), will vest on the first anniversary of the March 7, 2023 grant date (the "Grant Date"), and the remaining seventy-five percent (75%) of the shares will vest in equal monthly installments over the following three (3) years, in each case subject to continued employment through such vesting date. |
F2 | Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Company's common stock. |
F3 | One-third (1/3) of the RSUs subject to this grant under the Plan will vest on each of the first three (3) anniversaries of the Grant Date, in each case subject to continued employment through such vesting date. |